These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34361998)

  • 1. Seroprevalence of SARS-CoV-2 Antibodies and Factors Associated with Seropositivity at the University of Salamanca: The DIANCUSAL Study.
    Muro A; Belhassen-García M; Muñoz Bellido JL; Lorenzo Juanes H; Vicente B; Pendones J; Adserias J; Sánchez Hernández G; Rodríguez Rosa M; Vicente Villardón JL; Burguillo J; López Andaluz J; Martín Oterino JA; García Criado FJ; Barbero F; Morales AI; Galindo Villardón P; González Sarmiento R; On Behalf Of The Diancusal Team
    J Clin Med; 2021 Jul; 10(15):. PubMed ID: 34361998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of anti-SARS-CoV-2 IgG Antibodies in the Staff of a Public School System in the Midwestern United States.
    Lopez L; Nguyen T; Weber G; Kleimola K; Bereda M; Liu Y; Accorsi EK; Skates SJ; Santa Maria JP; Smith KR; Kalinich M
    medRxiv; 2020 Oct; ():. PubMed ID: 33140066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective analysis of seroprevalence in a cohort of university students of Rome (Italy) between September 2020 and July 2021.
    Ulivieri A; Morgante A; Magi F; Salehi LB; Lavra L
    Epidemiol Prev; 2022; 46(5-6):367-375. PubMed ID: 36628641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of antibodies against SARS-CoV-2 in the school community in Campo Grande, state of Mato Grosso do Sul, Brazil, October 2021-November 2022.
    Stutz C; Alcantara DMC; Dos Santos CM; Torres JM; Rodrigues R; Marcon GEB; Ferreira EC; Sarti ECFB; de Oliveira TF; Mendes FML; Lemos EF; Demarchi LHF; Lichs GGC; Zardin MCSU; Gonçalves CCM; Guilhermino JF; Perdomo RT; Fernandez ZDC
    Front Immunol; 2024; 15():1354786. PubMed ID: 38596680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, India.
    Lone KS; Khan SMS; Qurieshi MA; Majid S; Pandit MI; Haq I; Ahmad J; Bhat AA; Bashir K; Bilquees S; Fazili AB; Hassan M; Jan Y; Kaul RR; Khan ZA; Mushtaq B; Nazir F; Qureshi UA; Raja MW; Rasool M; Asma A; Bhat AA; Chowdri IN; Ismail S; Jeelani A; Kawoosa MF; Khan MA; Khan MS; Kousar R; Lone AA; Nabi S; Qazi TB; Rather RH; Sabah I; Sumji IA
    Front Public Health; 2022; 10():967447. PubMed ID: 36276377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological surveys to estimate cumulative incidence of SARS-CoV-2 infection in adults (Sero-MAss study), Massachusetts, July-August 2020: a mail-based cross-sectional study.
    Snyder T; Ravenhurst J; Cramer EY; Reich NG; Balzer LB; Alfandari D; Lover AA
    medRxiv; 2021 May; ():. PubMed ID: 33758898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in Catalonia, Spain.
    Peremiquel-Trillas P; Saura-Lázaro A; Benavente-Moreno Y; Casabonne D; Loureiro E; Cabrera S; Duran A; Garrote L; Brao I; Trelis J; Galán M; Soler F; Julià J; Cortasa D; Domínguez MÁ; Albasanz-Puig A; Gudiol C; Ramírez-Tarruella D; Muniesa J; Rivas JP; Muñoz-Montplet C; Sedano A; Plans À; Calvo-Cerrada B; Calle C; Clopés A; Carnicer-Pont D; Alemany L; Fernández E
    BMJ Open; 2022 Apr; 12(4):e056637. PubMed ID: 35450905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Cross-Sectional Study of Exposure Factors Associated with Seropositivity for SARS-CoV-2 Antibodies during the Second Epidemic Wave among a Sample of the University of Corsica (France).
    Decarreaux D; Sevila J; Masse S; Capai L; Fourié T; Saba Villarroel PM; Amroun A; Nurtop E; Vareille M; Pouquet M; Blanchon T; de Lamballerie X; Charrel R; Falchi A
    Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of anti-SARS-CoV-2 antibodies among children and their parents in Greece.
    Dimopoulou D; Kyritsi M; Dadouli K; Vergadi E; Tsiligianni E; Papadimitriou E; Mavridi A; Giannakopoulos S; Tsiourvopoulou G; Palyvou M; Angeli E; Brikos N; Eleftheriou I; Spoulou V; Michos A; Gkentzi D; Siomou E; Papaevangelou V; Grivea I; Syrogiannopoulos G; Galanakis E; Hadjichristodoulou C; Tsolia M
    Eur J Pediatr; 2023 Jan; 182(1):439-449. PubMed ID: 36383284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of Anti-SARS-CoV-2 Antibodies in Benadir Region, Somalia.
    Adam MH; Mohamoud JH; Mohamood AS; Mohamed AA; Garba B; Dirie NI
    Vaccines (Basel); 2022 Jan; 10(2):. PubMed ID: 35214678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study.
    Poustchi H; Darvishian M; Mohammadi Z; Shayanrad A; Delavari A; Bahadorimonfared A; Eslami S; Javanmard SH; Shakiba E; Somi MH; Emami A; Saki N; Hormati A; Ansari-Moghaddam A; Saeedi M; Ghasemi-Kebria F; Mohebbi I; Mansour-Ghanaei F; Karami M; Sharifi H; Pourfarzi F; Veisi N; Ghadimi R; Eghtesad S; Niavarani A; Ali Asgari A; Sadeghi A; Sorouri M; Anushiravani A; Amani M; Kaveh S; Feizesani A; Tabarsi P; Keyvani H; Markarian M; Shafighian F; Sima A; Sadjadi A; Radmard AR; Mokdad AH; Sharafkhah M; Malekzadeh R
    Lancet Infect Dis; 2021 Apr; 21(4):473-481. PubMed ID: 33338441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-SARS-CoV-2 Seropositivity Among Medical Students in Copenhagen.
    Madsen JR; Nielsen JPS; Fogh K; Hansen CB; Nielsen PB; Lange T; Hasselbalch RB; Garred P; Iversen K
    Open Forum Infect Dis; 2021 Aug; 8(8):ofab273. PubMed ID: 34423066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United States.
    Lopez L; Nguyen T; Weber G; Kleimola K; Bereda M; Liu Y; Accorsi EK; Skates SJ; Santa Maria JP; Smith KR; Kalinich M
    PLoS One; 2021; 16(6):e0243676. PubMed ID: 34111144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demographic and occupational determinants of anti-SARS-CoV-2 IgG seropositivity in hospital staff.
    Martin CA; Patel P; Goss C; Jenkins DR; Price A; Barton L; Gupta P; Zaccardi F; Jerina H; Duraisingham S; Brunskill NJ; Khunti K; Pareek M
    J Public Health (Oxf); 2022 Jun; 44(2):234-245. PubMed ID: 33200200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of initial SARS-CoV-2 seroprevalence in the most affected districts in the municipality of São Paulo, Brazil.
    Tess BH; Granato CFH; Alves MCGP; Pintão MCT; Nunes MC; Rizzatti EG; Reinach FC
    Braz J Infect Dis; 2021; 25(4):101604. PubMed ID: 34416142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Seroprevalence Against SARS-CoV-2 Among Faculty of Medicine and Health Sciences Personnel and Students of the University of Alcalá, Spain: Contributing Factors.
    Pérez-Tanoira R; Lledó García L; Torralba González de Suso M; Rodríguez Zapata M; Arroyo Serrano T; Giménez Pardo C; Rodríguez Pedrosa MI; Romero Badía MN; Pérez-García F; González López P; Villaescusa García C; Cuadros González J
    Int J Gen Med; 2021; 14():7017-7024. PubMed ID: 34707393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of SARS-CoV-2 infection and SARS-CoV-2-specific antibody detection among healthcare workers and hospital staff of a university hospital in Colombia.
    Caballero N; Nieto MA; Suarez-Zamora DA; Moreno S; Remolina CI; Durán D; Vega D; Rodríguez-Urrego PA; Gómez CP; Rojas DP; Ramírez A; Martínez O; Baldión-Elorza AM; Hernández LJ; Quintero J
    IJID Reg; 2022 Jun; 3():150-156. PubMed ID: 35720138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Cross-Sectional Study of SARS-CoV-2 Antibodies and Risk Factors for Seropositivity in Staff in Day Care Facilities and Preschools in Denmark.
    Fogh K; Eriksen ARR; Larsen TG; Hasselbalch RB; Bundgaard H; Scharff BFSS; Nielsen SD; Jørgensen CS; Erikstrup C; Østergaard L; Ellermann-Eriksen S; Andersen B; Nielsen H; Johansen IS; Wiese L; Hindhede L; Mikkelsen S; Sækmose SG; Aagaard B; Holm DK; Harritshøj L; Simonsen L; Fischer TK; Folke F; Lippert F; Ostrowski SR; Benfield T; Mølbak K; Ethelberg S; Koch A; Vangsted AM; Krause TG; Fomsgaard A; Ullum H; Skov R; Iversen K
    Microbiol Spectr; 2023 Feb; 11(1):e0417422. PubMed ID: 36546864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staff SARS-CoV-2 Seroprevalence and Mental Health as Key Factors in University Response to COVID-19 Pandemic.
    Lopes DG; Henriques AR; Santos-Dias M; Nunes-da-Silva C; Gonçalves J; de Sousa RD; Abdulghani S; Eletério J; Braga SJ; Soares H; Branco JC; Canhão H; Rodrigues AM
    Front Public Health; 2021; 9():689919. PubMed ID: 34222187
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.